ALS Limited (FRA:CP4)

Market Cap	7.03B +32.0%
Revenue (ttm)	1.98B +10.7%
Net Income	189.70M +24.4%
EPS	0.37 +20.0%
Shares Out	n/a
PE Ratio	37.07
Forward PE	24.95
Dividend	0.25 (1.85%)
Ex-Dividend Date	Jun 12, 2026

Volume	n/a
Open	13.60
Previous Close	13.40
Day's Range	13.60 - 13.60
52-Week Range	10.00 - 15.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 23, 2026

About ALS Limited

ALS Limited engages in the provision of professional technical services and analytical services primarily in the areas of testing, measurement, and inspection in Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States. It operates in two segments: Commodities and Life Sciences. The Commodities segment offers assaying and analytical testing, and metallurgical services for mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, opti...

• Industry: Testing Laboratories
• Founded: 1863
• Employees: 23,342
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CP4

Financial Performance

In fiscal year 2026, ALS Limited's revenue was 3.32 billion, an increase of 10.69% compared to the previous year's 3.00 billion. Earnings were 318.70 million, an increase of 24.40%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error